Assessing usability of electronic patient-reported outcome measures in older people with and without a rare dermatologic disorder
The results suggest that older people can confidently use a tablet or smartphone for ePROM completion, particularly with appropriate training. ePROMs should be designed with the needs of the target patient population in mind. These results can be leveraged to improve clinical data recording, optimize device usability, and enhance the user experience for older people and those with functional or physical limitations.
Authors
- Richard J. Bruce (ORCID: https://orcid.org/0000-0003-2004-8864)
- Kimberly Kelly
- Calvin N. Ho (ORCID: https://orcid.org/0000-0002-3360-9651)
- Anna Kündig
- Lila Bahadori
- Katy Roat
- Caroline P. Goswami
- Thomas Moll
Institutions
- IQVIA (United States) (US)
- AstraZeneca (France) (FR)
- AstraZeneca (Poland) (PL)
- AstraZeneca (Sweden) (SE)
- AstraZeneca (United States) (US)
- IQ Solutions (US)
Publication Details
- Journal
- Journal of Patient-Reported Outcomes
- Published
- 2024-12-18
- DOI
- https://doi.org/10.1186/s41687-024-00821-w
- Citations
- 1
- Primary Topic
- Autoimmune Bullous Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- AstraZeneca
- Johns Hopkins University